Patent · US Active

Lyophilized powder of latamoxef sodium for injection and lyophilization method thereof

US12350376B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventor

Key dates

Filing dateDec 29, 2021
Grant dateJul 8, 2025
Priority date
Expiry dateNov 17, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A lyophilized powder of latamoxef sodium for injection and a lyophilization method thereof are provided. The lyophilized powder of latamoxef sodium for injection includes the following raw materials by weight: 20˜40 parts of latamoxef sodium, 8˜15 parts of lyophilized adjuvant, 6˜18 parts of excipient and 30˜55 parts of water; by optimizing a raw material process thereof, the present disclosure prepares lyophilized adjuvant and performs twice drying, so that the raw material has stable quality, less impurities, high purity, less adverse reactions and high efficacy; at the same time, the preparation process is innovated and improved to reduce a preparation temperature and ensure stable quality of a drug solution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.